Can tuberculosis cause hemoptysis
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
I now have sufficient textbook content to give a comprehensive answer. Let me also quickly check the aspergilloma section since it's a major TB-related cause of hemoptysis.
Yes — tuberculosis is a well-established and important cause of hemoptysis. Here is a comprehensive breakdown:
Tuberculosis and Hemoptysis
Yes, tuberculosis (TB) can cause hemoptysis, and it is one of the most significant infectious causes worldwide. The mechanism depends on the stage and complications of the disease.
Mechanisms
1. Active cavitary TB
Active pulmonary TB classically produces upper-lobe cavities. Erosion of blood vessels within the cavity wall causes bleeding ranging from blood-streaked sputum to massive hemoptysis. The most feared vessel is the Rasmussen aneurysm — a pseudoaneurysm of a pulmonary artery branch that passes through or adjacent to a TB cavity. Rupture can cause life-threatening hemorrhage.
2. Bronchial artery hypertrophy (most common source)
Chronic TB-related inflammation and bronchiectasis causes reactive hyperplasia of bronchial arteries. These enlarged, tortuous vessels are the most common source of bleeding in TB-associated hemoptysis. Bronchial arteries are the culprit in 85–90% of massive hemoptysis cases overall, with TB being a leading etiology.
— Grainger & Allison's Diagnostic Radiology
3. Post-TB bronchiectasis
Healed TB leaves fibrotic, destroyed lung tissue with dilated, distorted airways (bronchiectasis), particularly in the upper lobes and superior segments of the lower lobes. These bronchiectatic areas have abnormally vascular walls prone to bleeding, even years to decades after the infection has resolved.
4. Aspergilloma in TB cavities
A residual TB cavity can be colonized by Aspergillus fumigatus, forming a mycetoma (fungal ball). Hemoptysis is the most important and potentially fatal complication of aspergilloma. The mechanism involves mechanical friction of the fungal mass against the cavity wall and local vascular invasion.
— Grainger & Allison's Diagnostic Radiology
5. Broncholithiasis
Calcified TB lymph nodes can erode into adjacent bronchi (broncholithiasis), causing airway obstruction, cough, and hemoptysis, more commonly on the right side.
— Grainger & Allison's Diagnostic Radiology
Severity
| Type | Description |
|---|---|
| Mild | Blood-streaked sputum — common in active TB |
| Moderate | >100 mL/day on 3+ occasions within 1 week |
| Massive | >300 mL over 24 hours — life-threatening, requires urgent intervention |
Management of TB-related Hemoptysis
- Bronchial artery embolization (BAE) is the first-line treatment for massive or recurrent hemoptysis. It provides immediate relief in 73–99% of cases. However, re-bleeding is likely if the underlying TB is not treated, as BAE does not address the root disease process.
- Anti-TB therapy is essential to stop ongoing tissue destruction.
- Surgery may be required for aspergilloma, localized destroyed lung, or failed embolization.
- Bronchoscopy can localize the bleeding site when bilateral disease is present.
— Grainger & Allison's Diagnostic Radiology
Key Takeaway
TB causes hemoptysis through multiple mechanisms at different disease stages — active cavitation during infection, and bronchiectasis, aspergilloma, or broncholithiasis as late sequelae. TB remains one of the most common global causes of massive hemoptysis, and the possibility of active or old TB should always be considered in any patient presenting with hemoptysis, particularly in endemic regions.
Can tuberculosis cause hemoptysis
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have excellent, authoritative textbook content from multiple sources. Here is a comprehensive answer:
Yes — Tuberculosis is a Major Cause of Hemoptysis
TB is one of the most important causes of hemoptysis globally, both during active infection and as a long-term sequela of healed disease.
Mechanisms
1. Cavitation and vascular erosion
Active pulmonary TB produces upper-lobe cavities. As cavitation progresses, the walls may erode into adjacent blood vessels. Hemoptysis often develops from complications of disease such as bronchiectasis or erosion into vascular malformations associated with cavitation.
— Schwartz's Principles of Surgery, 11th Ed.
The most feared vascular complication is a Rasmussen aneurysm — a pseudoaneurysm of a pulmonary artery branch running through the cavity wall. Rupture causes massive, potentially fatal bleeding.
2. Bronchiectasis (most common late cause)
Healed TB leaves fibrotic, scarred lung — particularly in the upper lobes — with irreversibly dilated, distorted airways. These bronchiectatic segments are fed by hypertrophied, tortuous bronchial arteries (high-pressure systemic circulation) that are prone to rupture. The bronchial arteries are the source of bleeding in 85–90% of massive hemoptysis cases overall.
— Fishman's Pulmonary Diseases and Disorders
3. Aspergilloma in a TB cavity
A residual TB cavity can be colonized by Aspergillus, forming a fungal ball (mycetoma). Hemoptysis — potentially massive — is the most important and dangerous complication of aspergilloma.
— Fishman's Pulmonary Diseases and Disorders
4. Broncholithiasis
Calcified TB lymph nodes can erode into adjacent bronchi. This causes cough, airway obstruction, and hemoptysis, more commonly on the right side.
— Grainger & Allison's Diagnostic Radiology
Severity Classification
| Grade | Volume |
|---|---|
| Mild | Blood-streaked sputum — common in active TB |
| Moderate | >100 mL/day on ≥3 occasions within 1 week |
| Massive (life-threatening) | >150 mL in 24 hours or ≥100 mL/hour |
Bronchiectasis, tuberculosis, bronchogenic carcinoma, and fungal infections are the most common causes of massive hemoptysis. Mortality from massive hemoptysis ranges from 7–30%, with death due to asphyxiation rather than exsanguination.
— Sabiston Textbook of Surgery
Management of TB-related Hemoptysis
- Airway protection first — position the patient in lateral decubitus with the bleeding lung dependent (prevents aspiration into the unaffected lung); supplemental oxygen; intubation if airway is compromised
- Bronchoscopy — localizes the bleeding site; allows local therapies (iced saline, epinephrine, balloon tamponade, electrocautery)
- CT angiography — identifies the source and provides a vascular road map; high sensitivity for bronchial and non-bronchial systemic arteries
- Bronchial artery embolization (BAE) — first-line definitive intervention; controls bleeding in 75–99% of cases. Re-bleeding occurs in 20–50% if the underlying TB is not treated
- Anti-TB therapy — essential; BAE does not address the underlying disease
- Surgery — resection of destroyed/cavitary lung for MDR-TB, failed embolization, or aspergilloma
— Harrison's Principles of Internal Medicine, 22nd Ed.; Sabiston Textbook of Surgery; Schwartz's Principles of Surgery
Key Clinical Point
In any patient presenting with hemoptysis — especially in TB-endemic regions, or with upper-lobe infiltrates/cavities/old fibrotic changes on imaging — active or previous TB must be high on the differential diagnosis list, even decades after the original infection.
Side effects of isoniazid
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive, authoritative content from Goodman & Gilman's, Sleisenger & Fordtran's, Harrison's, and Tintinalli's. Here is the full answer:
Side Effects of Isoniazid (INH)
1. Peripheral Neuropathy (most common)
The most frequent side effect of INH. It presents as paresthesias of the feet and hands.
- Occurs in ~2% of patients on standard doses (5 mg/kg/day)
- Rises to ≥17% at higher doses (>6 mg/kg/day)
- Mechanism: INH inhibits pyridoxal phosphokinase → pyridoxine (vitamin B6) deficiency → impaired GABA synthesis and axonal function
- At-risk groups: slow acetylators, elderly, malnourished, diabetic, anemic patients, those with renal insufficiency or alcoholism
- Prevention: pyridoxine 25–50 mg/day (up to 100 mg/day) co-administered with INH
— Harrison's Principles of Internal Medicine, 22nd Ed.; Goodman & Gilman's
2. Hepatotoxicity (most serious)
INH-induced liver injury is the most dangerous adverse effect.
- Transaminase elevation (AST/ALT): occurs in 10–36% of patients in the first 10 weeks — usually mild and resolves spontaneously even without stopping the drug
- Clinical hepatitis: develops in ~2% of exposed persons; 5–10% of hepatitis cases are fatal
- Severe hepatic injury: ~0.1% of all patients
- Most cases occur 4–12 weeks after starting therapy
- Risk increases with age: 0.3% in the 3rd decade → ≥2% after age 50
- Worsened by: chronic alcohol use, concomitant rifampin/pyrazinamide/acetaminophen, HIV, HCV, HBV co-infection, malnutrition
- 70% of fatal cases are in women; Black and Hispanic women at particular risk
- INH hepatotoxicity is the 2nd most common indication for liver transplantation due to drug-induced liver injury in the USA (after acetaminophen)
- Key principle: most deaths are preventable — stop INH immediately if symptoms develop
— Sleisenger & Fordtran's Gastrointestinal and Liver Disease; Goodman & Gilman's
3. Other Neurological Effects
| Effect | Details |
|---|---|
| Seizures | Especially in overdose or pre-existing epilepsy; due to B6 deficiency and GABA inhibition |
| Optic neuritis / atrophy | Rare; visual disturbance |
| Dizziness, ataxia | CNS effects |
| Toxic encephalopathy | Rare but serious |
| Stupor / coma | In overdose |
| Psychiatric effects | Euphoria, memory impairment, loss of self-control, psychosis |
| Muscle twitching | Due to pyridoxine depletion |
4. Hypersensitivity and Immune Reactions
- Drug-induced lupus (SLE-like syndrome): vasculitis with antinuclear antibodies — resolves on stopping INH
- Arthritic / rheumatic symptoms
- Rash, fever, eosinophilia (uncommon)
5. Miscellaneous
- Dry mouth, epigastric distress, nausea
- Methemoglobinemia
- Tinnitus
- Urinary retention
- Pyridoxine-deficiency anemia in predisposed individuals (responds to high-dose B6)
Overdose Toxicity — Classic Triad
Acute INH overdose (>20–30 mg/kg) produces a characteristic triad:
- Refractory seizures (generalized tonic-clonic; resistant to standard benzodiazepines)
- Metabolic acidosis (lactic acidosis from prolonged seizure activity)
- Protracted coma
Treatment: IV pyridoxine gram-for-gram equivalent to INH ingested (5 g IV if unknown dose) + benzodiazepines. Phenytoin has no role.
— Tintinalli's Emergency Medicine
Key Risk Factor: Acetylator Status
INH is metabolized by N-acetyltransferase 2 (NAT2):
- Slow acetylators: higher INH plasma levels → greater risk of neuropathy and hepatotoxicity
- Fast acetylators: lower plasma levels → risk of treatment failure; also generate more acetylhydrazine (hepatotoxic metabolite) via CYP2E1
- Fast acetylation is more common in Inuit and Japanese populations; slow acetylation predominates in Scandinavians and North Africans
— Goodman & Gilman's Pharmacological Basis of Therapeutics
Monitoring Recommendations
- Baseline LFTs; repeat if symptomatic or high-risk
- Stop INH if symptomatic hepatitis develops or if transaminases rise >3–5× ULN with symptoms
- Prescribe pyridoxine routinely in at-risk patients
- Monitor for neuropathy symptoms
This is a shared conversation. Sign in to Orris to start your own chat.